Puretech Health PLC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
PureTech Health plc filed its Form 20-F for the fiscal year ended December 31, 2025, detailing its financial performance, strategic outlook, and risk factors.
NASDAQ
PureTech Health PLC announces its 2024 financial results, showcasing key achievements in therapeutic development and strategic initiatives.
NASDAQ
PureTech Health PLC establishes a new performance share plan in 2023 to align executive incentives with shareholder value and company growth.